Automating Clinical Trial Processes Using BPM

Over the past decade, clinical trials have notoriously become plagued by problematic protocols, missed enrollment targets, and an unsettling level of redundancy and rework. Only about a third of drugs that enter clinical testing ever progress to large-scale phase III studies and success rate could decline further if healthcare reform moves up the norm for proving value over therapeutic alternatives. Life sciences companies forced